Medical University of South Carolina - Hollings Cancer Center - PPDS — Charleston, South Carolina

Medical University of South Carolina - Hollings Cancer Center - PPDS is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Medical University of South Carolina - Hollings Cancer Center - PPDS has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Neurofibromatosis 1, Plexiform Neurofibroma, NF1.

Sponsors: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., Takeda.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Medical University of South Carolina - Hollings Cancer Center - PPDS?

Medical University of South Carolina - Hollings Cancer Center - PPDS has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Medical University of South Carolina - Hollings Cancer Center - PPDS conducted?

Medical University of South Carolina - Hollings Cancer Center - PPDS has 2 clinical trials on record, with 2 currently active. Their work covers Neurofibromatosis 1, Plexiform Neurofibroma, NF1.

Is Medical University of South Carolina - Hollings Cancer Center - PPDS accredited by Crixeo Health?

Medical University of South Carolina - Hollings Cancer Center - PPDS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Medical University of South Carolina - Hollings Cancer Center - PPDS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.